![[logo] US EPA](http://www.epa.gov/epafiles/images/logo_epaseal.gif){kind=logo}
Targeted Grants to Reduce Childhood Lead Poisoning; Notice of Funds Availability
Note: EPA no longer updates this information, but it may be useful as a reference or resource.
[Federal Register: December 1, 2004 (Volume 69, Number 230)]
[Notices]
[Page 69913-69919]
From the Federal Register Online via GPO Access [wais.access.gpo.gov]
[DOCID:fr01de04-64]
-----------------------------------------------------------------------
ENVIRONMENTAL PROTECTION AGENCY
[OPPT-2004-0119; FRL-7686-8]
Targeted Grants to Reduce Childhood Lead Poisoning; Notice of
Funds Availability
AGENCY: Environmental Protection Agency (EPA).
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: EPA is soliciting grant proposals from eligible entities to
conduct activities to reduce incidences of childhood lead poisoning in
vulnerable populations, including projects to: (1) Address areas with
high incidences of elevated blood-lead levels; (2) identify and address
areas with high potential for heretofore undocumented elevated blood-
lead levels; (3) develop tools to address unique and challenging issues
in lead poisoning prevention; and (4) identify tools that are
replicable and scalable for other areas. Activities eligible for
funding include outreach and public education, data gathering,
monitoring, training, inspections and assessments, demonstrations, and
new, innovative approaches for identifying or reducing lead poisoning.
EPA is awarding grants which will provide a total of approximately
$750,000. The Agency anticipates awarding individual grants of $25,000
to $100,000. This grant program is open to a wide range of applicants,
including state governments, local governments, federally recognized
Indian Tribes and tribal consortia, territories, nonprofit
organizations, private and state-controlled institutions of higher
learning, and nonprofit organizations including community action
agencies and other organizations having 501(c)(3) status.
DATES: Proposals must be postmarked, faxed, or e-mailed to EPA on or
before January 31, 2005.
ADDRESSES: Proposals may be submitted by mail, fax, or electronically.
Please follow the detailed instructions provided in Unit IV. of the
SUPPLEMENTARY INFORMATION.
FOR FURTHER INFORMATION CONTACT: For specific information regarding
your geographic area or application, contact
[[Page 69914]]
the appropriate EPA Regional Lead Contact listed in Unit VII. of the
SupplementaryInformation.
SUPPLEMENTARY INFORMATION: The following listing provides certain key
information concerning this funding opportunity.
? Federal agency name: Environmental Protection Agency (EPA).
? Funding opportunity title: Targeted Grants to Reduce
Childhood Lead Poisoning.
? Funding opportunity number: FON-T001.
? Announcement type: The initial announcement of a funding opportunity.
? Catalog of Federal Domestic Assistance (CFDA) number: 66-716.
? Dates: Proposals must be postmarked, faxed, or e-mailed on
or before January 31, 2005. Projects are expected to be completed
within 2 years of award of the grant.
I. Funding Opportunity Description
A. Authority
Section 10 of the Toxic Substances Control Act (TSCA), as
supplemented by Public Law 106-74, authorizes EPA to award grants for
the purpose of conducting research, development, monitoring, education,
training, demonstrations, and studies necessary to carry out the
purposes of TSCA.
B. Program Description
1. Purpose and scope. EPA is soliciting grant proposals from
eligible entities to conduct activities to reduce incidences of
childhood lead poisoning in vulnerable populations, including projects
to: (1) Address areas with high incidences of elevated blood-lead
levels; (2) identify and address areas with high potential for
heretofore undocumented elevated blood-lead levels; (3) develop tools
to address unique and challenging issues in lead poisoning prevention;
and (4) identify tools that are replicable and scalable for other
areas. Activities eligible for funding include outreach and public
education, data gathering, monitoring, training, inspections and
assessments, demonstrations, and new, innovative approaches for
identifying or reducing lead poisoning.
EPA is awarding grants which will provide a total of approximately
$750,000. The Agency anticipates awarding individual grants of $25,000
to $100,000.
This grant program is open to a wide range of applicants, including
state governments, local governments, federally recognized Indian
Tribes and tribal consortia, territories, nonprofit organizations,
private and state-controlled institutions of higher learning, and
nonprofit organizations including community action agencies and other
organizations having 501(c)(3) status. This list is not intended to be
exhaustive, but rather provides a guide for readers regarding entities
likely to be eligible for these grants. Other types of entities not
listed in this unit could also be eligible.
2. Activities to be funded. EPA will provide financial assistance
in the form of grants to conduct any or all of the following activities:
i. Outreach (educational) activities, including but not limited to
development and conduct of organized outreach efforts to educate
families about the dangers to children from exposure to lead-based
paint hazards, distribution of educational information, and
encouragement of families to have their children screened for lead
poisoning and have their homes tested for lead hazards. Activities may
include, but are not limited to, training medical professionals,
developing culturally specific lead outreach materials, distributing
pamphlets, establishing an in-home education program to visit the homes
of young children, and promoting lead-safe work practices.
Grantees may develop their own outreach materials; however, the use
and reproduction of pre-existing products is strongly encouraged and
preferred. EPA and other Federal agencies have developed, and currently
provide, a wide range of outreach materials available from the National
Lead Information Center (1-800-424-LEAD). Any new lead awareness
materials developed must be consistent with the Federal (EPA,
Department of Housing and Urban Development (HUD), and Centers for
Disease Control and Prevention (CDC, formerly the Centers for Disease
Control)) lead hazard awareness and poisoning prevention programs
(http://www.epa.gov/lead/, http://www.hud.gov/offices/lead/, 
and http://www.cdc.gov/nceh/lead/lead.htm) and receive approval
from the appropriate EPA Regional Lead Contact listed in Unit VII.
ii. Data gathering, including but not limited to assessments such
as blood-lead screening and other activities described below,
particularly for areas without well-documented rates of lead poisoning.
This includes conducting blood-lead screening of children age 6 years
and under, preferably of children between the ages of 12-36 months
(blood-lead levels tend to be highest in this age group). (The CDC's
recommended level of concern that encourages follow-up activities is 10
[mu]g/dL, with specific actions/interventions recommended at various
elevated blood-lead levels.)
All blood-lead samples collected must be analyzed using a Clinical
Laboratory Improvement Amendments (CLIA)-certified laboratory.
Portable, hand-held blood-lead analyzers may be used, but must be
operated by a laboratory that is CLIA-certified for moderately complex
analysis. CLIA regulations, published in 1992 (42 CFR part 493), are
administered by the Centers for Medicare and Medicaid Services (CMS,
formerly the Health Care Finance Administration). CLIA-certified
laboratories must successfully participate in a testing proficiency
program that is CLIA approved. Information regarding CLIA may be
downloaded from the CMS web site at http://www.cms.gov/clia/.
EPA also encourages the development of new assessment methods which
may be used in lieu of blood-lead monitoring. In particular, EPA
encourages applicants to consider developing new tools to better target
populations at risk and to gauge the success of activities funded under
this program and other activities designed to combat childhood lead
poisoning.
iii. Inspections and risk assessments of pre-1978 housing and/or
child-occupied facilities for lead-based paint hazards. This includes
collection and analysis of paint, dust, and soil samples for hazardous
lead levels. Inspections and risk assessments may only be conducted by
individuals appropriately certified. Inspections and risk assessments
must be conducted according to the work practice standards found in 40
CFR 745.227 or those of the authorized state or tribal program.
Analysis of paint, dust, and soil samples must be conducted by a
National Lead Laboratory Accreditation Program (NLLAP)-recognized
laboratory. A current list of NLLAP-recognized laboratories can be
obtained by calling the National Lead Information Center at 1-800-424-
LEAD.
iv. Training. This includes training of individuals and of parents
and community members. Worker training includes training to perform
abatements, lead inspections, and risk assessments, including initial,
refresher, or any other training required to obtain certification to
perform lead-based paint inspections and risk assessments. Grant funds
cannot be used to pay for any administrative or testing fees for
certification to conduct lead inspections and/or risk assessments.
Training would also include training of other contractors in lead-safe
work practices.
[[Page 69915]]
Funds can also be used for training of parents and other community
members to do outreach and other efforts which do not require
certification.
v. Partnership development, including partnerships with public and
private entities which have expertise or experience in training, public
health, housing, education, nutrition, public education or public
relations, and other fields, as part of the performance of eligible
activities and which will improve our ability to eliminate childhood
lead poisoning.
vi. Quality assurance activities related to the above. All
environmental or health-related measurements or data generation must
adequately address the requirements of 40 CFR 30.54 and 31.45 relating
to quality assurance/quality control. Information on EPA quality
assurance requirements may be downloaded from the EPA Quality System
web site athttp://www.epa.gov/quality/. To begin the process of
developing the quality assurance documentation, a quality assurance
project plan template has been developed that may be helpful to use as
a guide. The template may be downloaded from the EPA/OPPT web site
at http://www.epa.gov/lead/new.htm. No testing or analytical work may
be performed without an approved quality assurance project plan. For
further guidance on preparation of the quality documentation and
specific EPA Regional Office approval requirements, please contact the
appropriate EPA Regional Lead Contact listed in Unit VII.
vii. Innovative approaches which have a high likelihood of
successfully identifying or reducing lead poisoning.
viii. Travel and related expenses consistent with the objectives of
this grant.
2. Goal and objectives. EPA seeks to award grants to entities best
able to undertake eligible activities (outreach and public education,
data gathering, monitoring, training, inspections and assessments,
demonstrations, and new, innovative approaches for identifying or
reducing lead poisoning) that accomplish one or more of the following
goals:
i. To reduce the incidence of childhood lead poisoning in areas of
vulnerable populations.
ii. To address areas with a high incidence of elevated blood-lead
levels in children, and also to identify and address areas with high
potential for elevated blood-lead levels in children.
iii. To develop tools to address unique and challenging issues in
lead poisoning prevention, including but not limited to special
situations affecting inner cities, Tribes, Federal facilities, etc.
iv. To identify tools that are replicable and scalable for other
areas combating lead poisoning.
EPA encourages applications addressing areas and/or populations
with high documented levels of lead poisoning, as well as proposals to
identify and address areas where there is great potential for elevated
blood-lead levels to exist, although screening and other data are
lacking. In the second case, applicants should submit rationale and
evidence to describe why a particular area would be advantageous for
EPA to invest in. In addition, the Agency encourages applications that
focus on populations at particular risk such as those that live in
inner cities, immigrant populations, those that live on Federal
facilities, Indian Tribes, etc.
EPA is interested in encouraging innovation, and recognizes that
smaller organizations may be uniquely situated to benefit populations
that are otherwise hard to reach. Therefore, the award process is open
to a wide range of applicants, including states, local governments,
Indian Tribes and tribal consortia, territories, nonprofits,
universities, and others.
II. Award Information
A total of $750,000 is available under this program at this time.
Applicants may receive grants of up to $100,000. EPA's intention is to
award 8 to 25 grants, including both smaller and larger grants,
assuming applications of sufficient quality are received. Final
distribution of the funds will be dependent upon the number of
qualified applicants, populations served by each grant, and other
factors as deemed appropriate by EPA, along with the evaluation
criteria as stated in Unit V.
Applicants may use a portion of the grant funds for contractor
support for these activities; however, contractor support may not
account for more than 25% of the amount of the grant, except where
contract services include blood-lead analysis, training, and/or lead-
based paint inspections and risk assessments.
III. Eligibility Information
1. Threshold eligibility factors. There are no threshold
eligibility factors under this grant program.
2. Eligibility criteria. Eligible recipients are those which have
the ability to directly address childhood lead poisoning in a given
population or area. This includes a wide range of potential applicants,
such as state governments, local governments, federally recognized
Indian Tribes and tribal consortia, territories, private and state-
controlled institutions of higher learning, and nonprofit organizations
including community action agencies and other organizations having
501(c)(3) status. This list is not intended to be exhaustive, but
rather provides a guide for readers regarding entities likely to be
affected by this action. Other types of entities not listed in this
unit could also be eligible.
3. Cost sharing or matching. There are no requirements for cost
sharing or matching funding under this grant program.
IV. Application and Submission Information
1. Address to request application package. To obtain an application
package, or for further information on individual applications, contact
the appropriate EPA Regional Lead Contact listed in Unit VII.
2. Content and form of application submission. To apply for a grant
under this program, submit one original and one copy of the grant
proposal, including a return mailing address, through the mail or
electronically to the appropriate EPA Regional Lead Contact listed in
Unit VII. The initial proposal must consist of no more than five pages
(excluding attachments), with page numbers. One page is one side of a
single-spaced typed letter-size page. Fonts must be 10 or 12 characters
per inch (cpi) and must have margins that are at least 1 inch. If a
package consists of more than five pages, the package will be
considered but the additional pages will not be reviewed.
If sent through the mail, grant proposals must be unbound, stapled,
or clipped in the upper lefthand corner, on white paper.
The format for the submission must address all of the elements
contained in Unit V., and must be organized and outlined as follows:
i. Project title, name of applicant, project contact, target
geographic location and/or population affected by the project, funding
requested, a statement as to whether this project addresses (a) an area
of high incidence of elevated blood-lead or (b) an area of suspected
but undocumented elevated blood-lead levels, and a one-paragraph
overview of your proposal describing how this project will identify
and/or reduce elevated blood-lead levels.
ii. Project narrative including:
? Problem statement.
? Specific goals and objectives (describe in measurable
terms the environmental or human health issue to be addressed).
? Project approach and tasks (steps you will take to reach
the goals, along with a timeline or schedule).
[[Page 69916]]
? Expected outcomes and results (what you hope to accomplish
and how you will measure and evaluate this).
? List of deliverables.
iii. Narrative addressing each evaluation criterion separately and
in the order shown in Unit V., in which you must describe how this
project will meet each criterion.
iv. Brief description of staffing, partners, and funding resources
which would be available to implement the proposed project, including
number of workers and staff qualifications (no resumes are required).
v. Brief description of the applicant's organization, experience
relating to lead poisoning prevention and to the target community, and
the organization's infrastructure as it relates to its ability to
implement the proposed project.
vi. Attachments must include letters of specific commitment, if
any, from partners, and draft Budget Forms 424-A and 424-B (these forms
must be finalized if your project is selected for funding).
3. Submission dates and times. All grant proposals must be
postmarked, e-mailed, or faxed on or before January 31, 2005.
4. Intergovernmental Review. Applicants should be aware that formal
requests for assistance (i.e., SF424 and associated documentation) may
be subject to intergovernmental review under Executive Order 12372,
``Intergovernmental Review of Federal Programs.'' Applicants should
contact their state's single point of contact (SPOC) for further
information. There is a list of these contacts at the following web
site: http://whitehouse.gov/omb/grants/spoc.html.
5. Funding restrictions. Grant funding may not be used for the
following:
i. Buying real property, such as land or buildings.
ii. Lead hazard reduction activities, such as performing interim
controls or abatement (as defined in 40 CFR 745.223). However, if your
proposal requests grant funding to pay for training activities, EPA is
interested in knowing how you plan to ensure those trained will be put
to work and how you will track the success of such a program.
iii. Construction activities, such as renovation, remodeling, or
building a structure.
iv. Lead-based paint certification fees for individuals and firms.
v. Contractor support in excess of 25% of the amount of the grant
award, except where contract services include blood-lead analysis,
training, and/or lead-based paint inspections and risk assessments.
This limit does not apply to developing quality assurance
documentation. However, while grantees may develop their own quality
assurance materials, pre-existing templates for inspection and
screening are available and EPA strongly encourages their use.
vi. Duplication of funding for any lead-related activities that are
being funded or have been previously funded by other EPA or other
Federal Government sources.
vii. Case-management costs, including medical treatment for
children with elevated blood-lead levels (e.g., followup visits by a
doctor or chelation therapy). EPA is extremely interested in knowing
what actions you plan to follow regarding monitoring, education, and/or
treatment for children whose blood-lead levels are determined under
this grant program to be elevated (greater than 10 [mu]g/dL). It is
important that the children who are found to have elevated blood-lead
levels are treated. Although most case-management costs are not
eligible for funding under the grant, a description of specific steps
and related information for followup activities must be included in the
work plan section of the grant proposal.
6. Other submission requirements. If the applicant has conducted,
or is currently working on a related project(s), a brief description of
those projects, funding sources, primary commitments, and an indication
as to whether those commitments were met must be included in the grant
proposal. The description must also indicate how the proposed project
is different from other funded work conducted by the applicant(s) or
unfunded work conducted by another entity, and how the proposed project
will not duplicate previous or on-going projects. However, EPA is
interested in knowing the extent to which these grants build upon or
support previous or other on-going projects, particularly those funded
by EPA or other Federal agency grant programs.
Grant proposals should be clearly marked to indicate any
information that is to be considered confidential. EPA will make final
confidentiality decisions in accordance with Agency regulations in 40
CFR part 2, subparts A and B.
V. Application Review Information
1. Criteria. EPA will review all proposals for quality, strength,
and completeness. The Agency will use the proposals to select projects
to be funded under this grant program. EPA reserves the right to reject
all proposals and make no awards. The evaluation criteria are as follows:
Criterion 1: Identifying and/or Addressing Vulnerable Populations at
Risk for Lead Poisoning (20 points)
For projects which address a community, population, or area with a
significantly higher than average incidence rate of childhood lead
poisoning, please address the following questions:
? What are the statistics illustrating that the target
community, population, or area has significantly higher than average
incidence rates of childhood lead poisoning? Please submit relevant
blood-lead monitoring data.
? What are the characteristics of the target areas/
populations, especially those which indicate that the need is critical?
Include demographic information for the target community and other
critical indicators including poverty rate, unemployment rate, special
community characteristics (e.g., population density, size), or other
factors that support the need for this project (e.g., low-income,
minority population, concentration of children, or communities
disproportionately impacted by environmental factors). Identify sources
of information used to illustrate current conditions.
? How will your proposed project lower the incidence and
severity of elevated blood-lead levels in children?
For projects that address a community, population, or area with a
high likelihood of higher than average incidence rates of childhood
lead poisoning, but where data or information is lacking, please
address the following questions:
? Why do you believe that this target area has a high
likelihood of higher than average incidence of childhood lead
poisoning? Please share all information that you have available to
understand the conditions in the target area (e.g., housing age and
quality, low-income, minority population, concentration of children, or
communities disproportionately impacted by environmental factors).
? Why is it important to better identify the remaining
vulnerable populations at risk in the target community, population, or
area?
? How will your project better identify the extent and
location of childhood lead poisoning (and lower the incidence and
severity of elevated blood-lead levels, if your project includes this
step)?
Criterion 2: Measurable Results (20 Points)
EPA prefers that progress be shown in real environmental progress
rather than solely in amount of work accomplished. Please describe the
extent to which the proposal measures both quantitative and
[[Page 69917]]
qualitative results. All project proposals must address the following
questions:
? What are the measurable short-term results that will be
achieved? Please describe measures that are based on outputs (e.g.,
number of brochures/surveys distributed), behavior changes (e.g.,
increase in number of children screened, implementing lead-safe
techniques), and/or environmental and human health results (e.g.,
decrease in elevated blood-lead levels, decrease in dust lead levels,
identification of actual elevated blood-lead levels in target area).
? How will you ensure that the data and information
collected are useable, accessible to the public, and are shared with
appropriate stakeholders?
? How will this project develop and encourage the use of
innovative techniques, tools, or measures which can identify vulnerable
populations at risk and/or measure improvements in environmental and
human health (e.g., surrogates for blood-lead testing)?
Criterion 3: Project Overview & Replicability (20 points)
EPA hopes to fund top quality projects that have a high likelihood
for success and replicability across the country. EPA intends to award
projects that reflect a broad range of areas and populations (e.g.,
urban, suburban, rural) and intends to showcase successful projects in
order to encourage replicability of successful efforts across the
country in areas facing similar challenges. Please include sufficient
detail to demonstrate whether the project approach is reasonable and
the use of resources is sound. All project proposals must address the
following questions:
? What are the project goals, tasks, and deliverables for the project?
? What are the characteristics of the target area/population
and are there other areas across the country that could benefit from
the proposed approach?
? If successful, how could this project, or methods used, be
replicated in other communities? Can this project serve as a model for
others to use in addressing problems and achieving results?
? What outputs of this project could serve to reduce
development, start-up, and/or research costs for other areas or populations?
Criterion 4: Critical Need & Leveraging Resources (20 points)
Please describe how the proposed project will fill a critical need
to reduce the incidence or suspected incidence of childhood lead
poisoning in the target community/area. In addition, please describe
the extent to which resources from this grant program can or will be
leveraged by other resources. All project proposals must answer the
following questions:
? What are the critical needs to identify the incidence or
reduce the incidence of childhood lead poisoning in the target
community/area?
? How will this project fit those needs?
? What resources are currently available for the type of
work proposed and why are they insufficient or unlikely to virtually
eliminate childhood lead poisoning in this community?
? How will any additional resources (e.g., funding, staff
time, in-kind resources) be leveraged for this project?
Criterion 5: Community Involvement and Effective Partnerships (15 points)
EPA believes that appropriate and effective community involvement
enhances the prospects for overall project success. Please describe the
extent to which the target community (e.g., area, neighborhood,
population) will be involved in the project. Does this project include
specific opportunities to empower the area/population to address the
project goals and objectives? Please describe the extent to which the
applicant will be partnering with local stakeholders (e.g., HUD, CDC
grantees, other EPA grantees, other Federal agencies, local community
groups, and/or health professionals) and the expected results of the
partnership. Letters of commitment will be reviewed as part of the
evaluation process and should explicitly state partner commitment
including roles and responsibilities on project. All project proposals
must address the following questions:
? How do your partners represent those in the target
community/area who have an interest in or will be affected by the project?
? What methods will be used for community involvement to
assure that all affected by the project will have the opportunity to
participate?
? What will your partners be responsible for as part of your
proposal and what commitments have they made to ensure the project's
success (e.g., funding, staff time, in-kind resources)?
Criterion 6: Sustainability & Evaluation (5 points)
Please describe the extent to which project components will be
evaluated, how the results will be compared to project goals, and how
effectiveness will be monitored and judged. Please also describe the
extent to which efforts will be made to continue project work beyond
the length of the grant period. All project proposals must answer the
following questions:
? How will needed changes to the project be identified and
incorporated on an ongoing basis?
? After the project is completed, how will results be
measured and evaluated to demonstrate how your project goals were met
and identify lessons learned?
? How does the project fit into an overall strategic plan to
address lead poisoning?
? After funds from EPA are exhausted, will any part of the
work continue? What will be done to increase the likelihood of further
work in the proposed target community/area?
2. Review and selection process. Award decisions will be made on
the basis of the initial package. Decisions on awarding the grant funds
will be made based on the evaluation of the proposals using the
criteria specified in Unit IV. Entities that submit qualifying
proposals will be notified by EPA of their selection and will be
required to submit official grant applications as a part of the award
process. Upon notice of award, you will be given 1 month to submit an
official grant application as part of the award process prior to
receipt of funds. Materials needed for the official grant application,
as well as further information on individual applications, may be
obtained though the appropriate EPA Regional Lead Contact listed in
Unit VII.
All initial grant proposals received under this notice are subject
to the dispute resolution process defined at 40 CFR 30.63 and 40 CFR
part 31, subpart F.
Should additional funding become available for award, EPA may award
additional grants based on this solicitation, in accordance with and at
the time of the final selection process, without further notice or
competition.
VI. Award Administration Information
1. Award notices. Once proposals have been reviewed and evaluated,
the contact person for the applicant (as identified in the proposal)
will receive notification from EPA in writing regarding the outcome of
the competition. If proposals are selected, additional forms for grant
application (such as Standard Form SF-424, Application for Federal
Assistance) will be required to be submitted to EPA. The specific
information will be provided in the written notification from EPA. In
addition, successful applicants will be required to certify that they
have not been debarred or suspended from participation in Federal
assistance awards in accordance with 40 CFR part 32. The application
forms are available on line at http://www.epa.gov/ogd/AppKit/
application.htm. These forms
[[Page 69918]]
should not be submitted with the proposals.
2. Administration and national policyrequirements--Quality
assurance. EPA's quality assurance requirements must be complied with
before any environmental or health-related measurements or data are
initiated under this grant. These requirements are addressed in 40 CFR
30.54 and 40 CFR 31.45 relating to quality assurance/quality control.
Information on EPA quality assurance requirements may be downloaded
from the EPA Quality System web site at http://www.epa.gov/quality/.
For further guidance on preparation of the quality documentation, and
specific EPA Regional approval requirements, please contact the
appropriate EPA Regional Lead Contact listed in Unit VII.
3. Statutory authority and Executive Order reviews. Section 10 of
TSCA, as supplemented by Public Law 106-74, authorizes EPA to award
grants for the purpose of conducting research, development, monitoring,
education, training, demonstrations, and studies necessary to carry out
the purposes of the Act. Presently, these funds are not eligible for
use in a Performance Partnership Agreement. The CFDA number is 66-716.
Applicants should be aware that formal requests for assistance (i.e.,
SF-424 and associated documentation) may be subject to
intergovernmental review under Executive Order 12372,
``Intergovernmental Review of Federal Programs.'' Applicants should
contact their state's single point of contact (SPOC) for further
information. There is a list of these contacts at the following web
site: http://whitehouse.gov/omb/grants/spoc.html.
4. Reporting. The grantee must provide EPA with written progress
reports within 30 days after the end of each quarter and a report
within 90 days after the end of the project period.
VII. Agency Contact
For specific information regarding your geographic area or
application, contact the appropriate EPA Regional Lead Contact. Grant
proposals must be submitted by mail or e-mail to the appropriate EPA
Regional Lead Contact. The EPA Regional Lead Contacts are listed as
follows:
Region 1 (Connecticut, Maine, Massachusetts, New Hampshire, Rhode
Island, and Vermont): Regional Contact: James M. Bryson, USEPA Region 1
(CPT), One Congress St., Suite 1100, Boston, MA 02114-0203; telephone
number: (617) 918-1524; fax number: (617) 918-0524; e-mail
address:bryson.jamesm@epa.gov.
Region 2 (New Jersey, New York, Puerto Rico, and the Virgin
Islands): Regional Contact: Lou Bevilacqua, USEPA Region 2 (MS 225),
2890 Woodbridge Ave., Edison, NJ 08837; telephone number: (732) 321-
6671; fax number: (732) 321-6757; e-mail
address:bevilaqua.louis@epa.gov.
Region 3 (Delaware, Maryland, Pennsylvania, Virginia, West
Virginia, and the District of Columbia): Regional Contact: Demian
Ellis, USEPA Region 3 (3WC33), 1650 Arch St., Philadelphia, PA 19103-
2029; telephone number: (215) 814-2088; fax number: (215) 814-3114; e-
mail address: ellis.demian@epa.gov.
Region 4 (Alabama, Florida, Georgia, Kentucky, Mississippi, North
Carolina, South Carolina, and Tennessee): Regional Contact: Liz Wilde,
USEPA Region 4, 61 Forsyth St., SW., Atlanta, GA 30303; telephone
number: (404) 562-8998; fax numbers: (404) 562-8973 and (404) 562-
8972;e-mail address: wilde.liz@epa.gov.
Region 5 (Illinois, Indiana, Michigan, Minnesota, Ohio, and
Wisconsin): Regional Contact: David Turpin, USEPA Region 5 (DT 8J), 77
W. Jackson Blvd., Chicago, IL 60604; telephone number: (312) 886-7836;
fax number: (312) 353-4788; e-mail address: turpin.david@epa.gov.
Region 6 (Arkansas, Louisiana, New Mexico, Oklahoma, and Texas):
Regional Contact: Eva Steele, USEPA Region 6, 1445 Ross Ave., 12th
Floor (6PD T), Dallas, TX 75202; telephone number: (214) 665-7211; fax
number: (214) 665-6762; e-mail address: steele.eva@epa.gov.
Region 7 (Iowa, Kansas, Missouri, and Nebraska): Regional Contact:
Larry Stafford, USEPA Region 7, ARTD/RALI, 901 North 5th, Kansas City,
KS 66101; telephone number: (913) 551-7394; e-mail
address:stafford.larry@epa.gov.
Region 8 (Colorado, Montana, North Dakota, South Dakota, Utah, and
Wyoming): Regional Contact: Amanda Hasty, USEPA Region 8, 999 18th St.,
Suite 300, Denver, CO 80202; telephone number: (303) 312-6966; fax
number (303) 312-6044; e-mail address:hasty.amanda@epa.gov.
Region 9 (Arizona, California, Hawaii, Nevada, American Samoa, and
Guam): Regional Contact: Nancy Oien, USEPA Region 9 (CMD 4), 75
Hawthorne St., San Francisco, CA 94105, telephone number: (415) 972-
3780; fax number: (415) 947-3583; e-mail address: oien.nancy@epa.gov.
Region 10 (Alaska, Idaho, Oregon, and Washington): Regional
Contact: Barbara Ross, USEPA Region 10, Solid Waste and Toxics Unit
(AWT 128), 1200 Sixth Ave., Seattle, WA 98101, telephone number: (206)
553-1985; fax number: (206) 553-8509; e-mail
address:ross.barbara@epa.gov.
VIII. Other Information
A. Does this Action Apply to Me?
This action may be of particular interest to those who have the
ability to directly address childhood lead poisoning in a given
population or area, such as state governments, local governments,
federally recognized Indian Tribes and tribal consortia, territories,
private and state-controlled institutions of higher learning, and
nonprofit organizations including community action agencies and other
organizations having a 501(c)(3) status. Since other entities may also
be interested, the Agency has not attempted to describe all the
specific entities that may be affected by this action. If you have any
questions regarding the applicability of this action to a particular
entity, consult the appropriate EPA Regional Lead Contact listed in
Unit VII.
B. How Can I Access Copies of this Document and Other Related Documents?
1. Docket. EPA has established an official public docket for this
action under docket identification (ID) number OPPT 2004-0119. The
official public docket is the collection of materials that is available
for public viewing at the EPA Docket Center, Rm. B-102 Reading Room,
EPA West, 1301 Constitution Ave., NW., Washington, DC. The EPA Docket
Center is open from 8:30 a.m. to 4:30 p.m., Monday through Friday,
excluding legal holidays. The EPA Docket Center Reading Room telephone
number is (202) 566-1744, and the telephone number for the OPPT Docket,
which is located in EPA Docket Center, is (202) 566-0280.
2. Electronic access. You may access this Federal Register document
electronically through the EPA Internet under the ``Federal Register''
listings at http://www.epa.gov/fedrgstr/. An electronic version of the
public docket is available through EPA's electronic public docket and
comment system, EPA Dockets. You may use EPA Dockets at http://
www.epa.gov/edocket/ to submit or view public comments, access the
index listing of the contents of the official public docket, and to
access those documents in the public docket that are available
electronically. Although not all docket materials may be available
electronically, you may still access any of the publicly available
docket materials through the docket facility identified in Unit
VIII.B.1. Once
[[Page 69919]]
in the system, select ``search,'' then key in the appropriate docket ID
number.
IX. Submission to Congress and the Comptroller General
Grant solicitations such as this are considered rules for the
purpose of the Congressional Review Act (CRA). The CRA, 5 U.S.C. 801 et
seq., as added by the Small Business Regulatory Enforcement Fairness
Act of 1996 (SBREFA), generally provides that before a rule may take
effect, the agency promulgating the rule must submit a rule report,
which includes a copy of the rule, to each House of the Congress and to
the Comptroller General of the United States. EPA will submit a report
containing this rule and other required information to the U.S. Senate,
the U.S. House of Representatives, and the Comptroller General of the
United States prior to publication of the rule in the Federal Register.
This is not a ``major rule'' as defined by 5 U.S.C. 804(2).
List of Subjects
Environmental protection, Grants, Lead, Lead-based paint, Maternal
and child health.
Dated: November 24, 2004.
Margaret Schneider,
Acting Assistant Administrator, Office of Prevention, Pesticides and
Toxic Substances.
[FR Doc. 04-26474 Filed 11-30-04; 8:45 am]
BILLING CODE 6560-50-S